OliX Pharmaceuticals Inc Ordinary Shares 226950
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- —
- Day Range
- KRW 15,440.00–15,800.00
- 52-Week Range
- —–—
- Bid/Ask
- KRW 15,740.00 / KRW 15,770.00
- Market Cap
- KRW 252.31 Bil
- Volume/Avg
- 7,866 / 108,851
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 12.62
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
OliX Pharmaceuticals Inc is a clinical stage biotechnology company. It is engaged in developing RNA interference (RNAi) technology therapeutics for dermal, ophthalmic and pulmonary diseases. The company’s pipeline products include OLX101, OLX201, OLX301, OLX102, and others.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 76
- Website
- http://www.olixpharma.com
Comparables
Valuation
|
Metric
|
226950
|
321550
|
115450
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | — |
Price/Book Value | 5.63 | 3.02 | 5.48 |
Price/Sales | 12.62 | 36.44 | 15.90 |
Price/Cash Flow | — | — | — |
Price/Earnings
226950
321550
115450
Financial Strength
|
Metric
|
226950
|
321550
|
115450
|
|---|---|---|---|
Quick Ratio | 4.71 | 3.67 | 1.57 |
Current Ratio | 4.90 | 3.88 | 1.86 |
Interest Coverage | −4.57 | −7.20 | −2.63 |
Quick Ratio
226950
321550
115450
Profitability
|
Metric
|
226950
|
321550
|
115450
|
|---|---|---|---|
Return on Assets (Normalized) | −17.58% | −15.28% | −5.29% |
Return on Equity (Normalized) | −44.79% | −34.91% | −7.14% |
Return on Invested Capital (Normalized) | −19.37% | −17.65% | −5.72% |
Return on Assets
226950
321550
115450
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Qpwdxlcqhx | Wth | $554.7 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Zslczbgbm | Fjsjsyz | $102.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Fdffdcdq | Rqpqym | $97.3 Bil | |
MRNA
| Moderna Inc | Ypybbdh | Rzfv | $41.3 Bil | |
ARGX
| argenx SE ADR | Pwszrwnd | Cznh | $22.3 Bil | |
BNTX
| BioNTech SE ADR | Svhhgvqmh | Tvlst | $21.0 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Vlpxwcxzl | Cmcpjm | $18.2 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Hjhbhbpc | Gqvbplw | $15.4 Bil | |
RPRX
| Royalty Pharma PLC Class A | Lmbkgrlvg | Ppxgd | $12.6 Bil | |
INCY
| Incyte Corp | Fbtxkxhl | Svyhrjz | $11.6 Bil |